Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma

International Journal of Hematology

Volumn 82, Issue 4, 2005, Pages 312-314

  Jabr, Fadi I ^a,b  

^a METROPOLITAN HOSPITAL CENTER   (United States)

^b Health Associates Peace Harbor   (United States)

Author keywords

Acute tumor lysis syndrome (ATLS); Anti CD20 monoclonal antibody; Diffuse large B cell lymphoma; Non Hodgkin's lymphoma (NHL); Rituximab

Indexed keywords

ALLOPURINOL; CD20 ANTIBODY; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIPHENHYDRAMINE; DOXORUBICIN; FUROSEMIDE; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPERURICEMIA; KIDNEY FAILURE; LACTIC ACIDOSIS; LEUKEMIA; LUNG EDEMA; LYMPHOMA; PNEUMONIA; TACHYCARDIA; TUMOR LYSIS SYNDROME;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; FATAL OUTCOME; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LYMPHOBLASTIC; MIDDLE AGED; TUMOR LYSIS SYNDROME;

EID: 33644680271     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.NA0504     Document Type: Article

References (8)

1. Maloney DG, Smith B, Rose A. Rituximab: mechanism of action and resistance. Semin Oncol 2002;29:29(1 suppl 2):2-9.
2. Bienvenu J, Chvetzoff R, Salles G, et al. Tumor necrosis factor alpha is a major biological event associated with rituximab treatment. Hematol J. 2001;2:378-384.
3. Dillman RO. Infusion reactions associated with the therapeutic use of monoclonal antibodies in the treatment of malignancy. Cancer Metastasis Rev. 1999;18:465-471.
4. Jensen M, Winker U, Manzke O, Diehl V, Engert A. Rapid tumor lysis in a patient with B-cell chronic lymphocyte leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab). Ann Hematol. 1998;77:89-91.
5. Yang H, Rosove MH, Figlin RA. Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Am J Hematol. 1999;62:247-250.
6. Mourad YA, Taher A, Shamseddine A. Acute tumor lysis syndrome in large B-cell non-Hodgkin lymphoma induced by steroids and anti-CD 20. Hematol J. 2003;4:222-224.
7. Cohen LG, Balow JE, Macgrath IT, Poplack DG, Ziegler JL. Acute tumor lysis syndrome: a review of 37 patients with Burkitt's lymphoma. Am J Med. 1980;68:486-491.
8. Dhingra K, Newcom SR. Acute tumor lysis syndrome in non-Hodgkin lymphoma induced by dexamethasone. Am J Hematol. 1988;29:115-116.